2016 ADX
2016 ADX Banner

Cambridge Healthtech Institute’s Sixth Annual
Commercialization of Molecular Diagnostics
August 24-25, 2016 | Grand Hyatt Washington| Washington, DC

Launching molecular diagnostics in the marketplace involves expertise in demonstrating the value proposition of the test, meanwhile carefully managing resources and navigating a competitive environment. Rising healthcare costs have led to innovative solutions which include molecular testing matched with targeted therapies, point-of-care testing to provide rapid results for improved patient outcomes, and non-invasive testing options. Attendees can plan to participate in the discussion with expert faculty in the field as they share insights and best practices for handling regulatory approval, reimbursement and clinical adoption to achieve commercial success.

This meeting will outline best practices for a commercialization strategy, including:

  • Review latest PAMA guidelines for impact on IVDs
  • Debate payer consolidation: Good news for industry?
  • Discuss prospects ahead for regulation of LDTs
  • Assess evidence required for clinical utility
  • Understand latest efforts to gain regulatory clearance of NGS assays and incorporate in the clinic
  • Measure the growth of non-invasive testing and evaluate obstacles to advancement
  • Realize market dynamics and keys to success
  • Develop new constructs with payers to gain reimbursement

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality conference program.

If you are interested in presenting, please click here. Replies to proposals can take up to 8-12 weeks. We will notify you once the agenda has been finalized.

Deadline for submission is February 5, 2016.

We welcome your comments, suggestions and speaker suggestions as we shape the 2016 program.

Sincerely,

Christina Lingham

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: (+1) 781-972-5464
E: clingham@healthtech.com

For exhibit & sponsorship opportunities, please contact:
Joseph Vacca, M.Sc.
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com


2015 Brochure

2015-Next-Generation-Diagnostics-Summit-Brochure-Thumb


Premier Sponsor 

Precision for Medicine 

View All Sponsors

View Media Partners

Media Gallery Thumb

Related Products

Fourth International Molecular Diagnostics Europe
 
MDX_Logo_150x150